- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06154798
World Digital Detox Program for Enhancing Women's Health & Well-being
Effectiveness of World Digital Detox Program on Psychological Distress, Psychosocial Factors, Menopause Symptoms, and Physical Health Outcome in Women: Pragmatic Randomized Controlled Trial
The concept of a digital detox, involving a deliberate reduction or elimination of digital device usage, has emerged as a potential strategy to mitigate the adverse effects of technology on mental and physical well-being. However, the specific effects of a structured digital detox program on psychological distress, psychosocial factors, menopause symptoms, and overall physical health in a community context remain underexplored.
This study seeks to address this gap by conducting a real-world trial, examining the impact of a digital detox program tailored for women. By delving into the intricacies of how digital technology interacts with the unique challenges faced by women, this research aims to contribute valuable insights into the development of real-world-driven interventions that promote the holistic well-being of women in the digital age.
Study Overview
Status
Intervention / Treatment
Detailed Description
Excessive screen time and social media use during menopause pose multifaceted challenges. Prolonged exposure to screens can disrupt sleep patterns and exacerbate existing sleep disturbances, impacting the hormonal balance crucial for menopausal women. Social media's potential to induce stress, anxiety, and negative self-perception adds an emotional layer, while sedentary screen-related behavior may contribute to physical health concerns such as weight gain and decreased bone density, issues already pertinent to menopausal women. The impact on interpersonal relationships, cognitive function, body image, and time management further complicates the landscape, highlighting the need for mindful strategies to navigate the intersection of menopause and digital habits.
The World Digital Detox Program, developed by the Zep Foundation, takes a comprehensive approach to address challenges associated with increased screen and social media use, extending its focus to encompass the unique challenges faced by women during menopause. The concept of a digital detox, involving a deliberate reduction or elimination of digital device usage, has emerged as a potential strategy to mitigate the adverse effects of technology on mental and physical well-being.
The overarching aim is to enhance the comprehensive well-being of women in the digital era, going beyond addressing broad concerns of prolonged screen usage. The focus is on tailoring interventions to meet the distinct needs of women navigating the complexities of menopause. This involves incorporating practices such as breathwork, exercise, dietary adjustments, and overall well-being strategies, ensuring a holistic approach that considers the unique challenges and requirements of women during this life stage.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maharashtra
-
Mumbai, Maharashtra, India
- World Digital Detox Day
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Menopausal staging: perimenopause or postmenopausal as per STRAW definitions
- Speak, read, and write in English sufficiently to comprehend materials in group treatment.
Exclusion Criteria:
- Participants who are severely depressed
- Need for acute treatment
- Participants with Psychotic Disorders, or current Substance Dependence.
- On Hormonal Replacement Therapy or intent to in next 3-months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: World Digital Detox Women's Health Program
The intervention is a 6-week World Digital Detox Program designed to help participants reduce their dependence on digital devices and foster a healthier balance between technology use and overall well-being.
|
World Digital Detox Women's Health Program incorporates gradual steps, including mindfulness exercises, setting boundaries on digital usage, decluttering digital spaces, promoting offline connections, and encouraging mindful technology use.
|
|
No Intervention: Control Group
Participants assigned to the control group will continue with their regular, unrestricted digital device usage throughout the 6-week study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Menopausal Health-Related Quality of Life
Time Frame: Baseline to 6-weeks post intervention
|
Menopausal Health-Related Quality of Life -38 items questionnaire score on a 4-point or binary scale covering 4 major domains (physical health, mental health, life satisfaction, and social involvement) of a woman's health during the menopausal transition
|
Baseline to 6-weeks post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Global Impression Scale (CGI)
Time Frame: Baseline to 6-weeks post intervention
|
The CGI is rated on a 7-point scale, with the severity of illness scale using a range of responses from 1 (normal) through to 7 (amongst the most severely ill patients).
|
Baseline to 6-weeks post intervention
|
|
Client Satisfaction Questionnaire (CSQ)
Time Frame: Baseline to 6-weeks post intervention
|
CSQ-8 items scores on a 4-point scale (possible range from eight to 32, where a higher score indicates a higher level of overall satisfaction with services,
|
Baseline to 6-weeks post intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Rekha Chaudhari, PhD, World Digital Detox Day, Zep Foundation
- Study Chair: Neha Sharma, PhD, Aarogyam UK
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Zep-WDDD-I 02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Western Norway University of Applied SciencesCompleted
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
Aydin Adnan Menderes UniversityUludag UniversityCompletedMenopause | Menopause Related ConditionsTurkey (Türkiye)
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasCompletedMenopause Related ConditionsUnited States
Clinical Trials on World Digital Detox Women's Health Program
-
Innowage LimitedAarogyam UK; Zep FoundationCompletedAdolescent Behavior | Family | Psychological Well-BeingIndia
-
Pack HealthGlaxoSmithKline; University of WashingtonRecruitingMultiple Myeloma | Relapsed Hematologic MalignancyUnited States
-
University of TorontoCanadian Institutes of Health Research (CIHR)RecruitingCardiovascular Diseases | Dyslipidemia | Cardiovascular Risk Factors | Cholesterol | Major Cardiovascular EventCanada
-
Chang Hsiu-JuNational Science and Technology Council, TaiwanCompletedDepressive SymptomsTaiwan
-
National University of SingaporeNot yet recruitingAged | Cognition | Digital Health LiteracySingapore
-
Johns Hopkins UniversityAmgen; NewAmsterdam PharmaRecruitingCardiovascular Risk | Implementation Science | Lipids | Digital Health | LDL-CUnited States
-
Pack HealthM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; The University... and other collaboratorsRecruitingBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Metastatic Cancer | Metastatic Breast Cancer | Endometrial Cancer | Head and Neck Cancers | Survivorship | Geriatric Oncology | Prostate CancersUnited States
-
Pack HealthM.D. Anderson Cancer Center; Sanofi; University of WashingtonRecruitingMultiple Myeloma | Refractory Multiple MyelomaUnited States
-
Chang Gung Memorial HospitalCompletedHealth Promotion | Hyperuricemia | Sleep Quality | Type 2 Diabetes Mellitus (T2DM) | Hypertension (HTN) | Hypercholesterolemia and Hyperlipidemia | Overweight (BMI > 25)Taiwan
-
Medical University InnsbruckCompleted